FARADAY PHARMACEUTICALS Trademark

Trademark Overview

On Wednesday, April 15, 2020, a trademark application was filed for FARADAY PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the FARADAY PHARMACEUTICALS trademark a serial number of 88873624. The federal status of this trademark filing is REGISTERED as of Tuesday, May 24, 2022. This trademark is owned by Faraday Pharmaceuticals, Inc.. The FARADAY PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of cardiac and skeletal muscle function disorders
faraday pharmaceuticals

General Information

Serial Number88873624
Word MarkFARADAY PHARMACEUTICALS
Filing DateWednesday, April 15, 2020
Status700 - REGISTERED
Status DateTuesday, May 24, 2022
Registration Number6732368
Registration DateTuesday, May 24, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 23, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of cardiac and skeletal muscle function disorders
Disclaimer with Predetermined Text"PHARMACEUTICALS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 24, 2020
Primary Code005
First Use Anywhere DateMonday, January 31, 2022
First Use In Commerce DateMonday, January 31, 2022

Trademark Owner History

Party NameFaraday Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98102
Party NameFaraday Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98102
Party NameFaraday Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98102

Trademark Events

Event DateEvent Description
Tuesday, May 24, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 24, 2022REGISTERED-PRINCIPAL REGISTER
Wednesday, April 13, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 12, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, April 11, 2022STATEMENT OF USE PROCESSING COMPLETE
Monday, March 21, 2022USE AMENDMENT FILED
Monday, April 11, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 21, 2022TEAS STATEMENT OF USE RECEIVED
Saturday, August 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 19, 2021SOU EXTENSION 1 GRANTED
Thursday, August 19, 2021SOU EXTENSION 1 FILED
Thursday, August 19, 2021TEAS EXTENSION RECEIVED
Tuesday, May 18, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 23, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 23, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 3, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 15, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 12, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 11, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 11, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Saturday, January 23, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Saturday, January 23, 2021FINAL REFUSAL E-MAILED
Saturday, January 23, 2021FINAL REFUSAL WRITTEN
Tuesday, December 22, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 22, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 22, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 1, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 1, 2020NON-FINAL ACTION E-MAILED
Wednesday, July 1, 2020NON-FINAL ACTION WRITTEN
Wednesday, July 1, 2020ASSIGNED TO EXAMINER
Friday, April 24, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, April 18, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharmaceuticals faraday muscle function disorders skeletal cardiac preparations prevention treatment pharmaceutical